- Home
- CRVO
CRVO
CervoMed Inc.
as 07-26-2024 4:00pm EST
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 160.4M | IPO Year: | N/A |
| Target Price: | $58.25 | AVG Volume (30 days): | 85.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.00 - $26.38 | Next Earning Date: | 08-06-2024 |
| Revenue: | $6,364,310 | Revenue Growth: | 352.05% |
| Revenue Growth (this year): | 23.25% | Revenue Growth (next year): | -40.54% |
Latest CervoMed Inc. News
CRVO Breaking Stock News: Dive into CRVO Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
CervoMed to Participate in the Emerging Growth Conference
GlobeNewswire
10 days ago
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
GlobeNewswire
15 days ago
CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024
Simply Wall St.
a month ago
CervoMed (NASDAQ:CRVO) Is In A Good Position To Deliver On Growth Plans
GlobeNewswire
a month ago
CervoMed Announces Addition to Russell 2000® and Russell 3000® Indexes
GlobeNewswire
a month ago
CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies
Zacks Small Cap Research
2 months ago
CRVO: Enrollment Set to Complete in Phase 2b RewinD-LB Trial in 2Q24; Topline Data in 4Q24…
MT Newswires
2 months ago
--JonesTrading Starts CervoMed With Buy Rating, $70 Price Target
Compare CRVO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRVO CervoMed Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.